Innovation Pharmaceuticals Inc (IPIX)

[kris_kade]

Not that I doubt the statment in the CTIX PR release but mainly for me to better understand the reasoning behaind the combo therapy when sunitinib alone is shown to shrink RCC tumors.

Again from this article: http://www.news-medical.net/health/Renal-Cell-Carcinoma-Treatments.aspx


The benefit for sunitinib was significant across all major patient subgroups, including those with a poor prognosis at baseline. 28% of sunitinib patients had significant tumor shrinkage compared with only 5% of patients who received interferon-a.

Maybe I am missing something here..